ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Geriatric Medicine

Top Geriatric Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT MIDENCE MD

Geriatric Medicine

7,725

$516K

550
521 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

MICHELLE ESTEVEZ MD

Geriatric Medicine

1,590

$105K

183
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $56

CHARLES HERRERA M.D.

Geriatric Medicine

9,863

$384K

499
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

ASOK ROY MD

Geriatric Medicine

604

$31K

110
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

48%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

JASON STIBICH M.D.

Geriatric Medicine

10,808

$684K

735
633 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

PATRICK BERGER D.O.

Geriatric Medicine

625

$30.7K

246
184 are 65+

8%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $56

JIANHONG HUA MD

Geriatric Medicine

1,201

$36.5K

133
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$30
Average prescription price

Avg: $56

SANDHYA NEMADE M.D.

Geriatric Medicine

2,288

$126K

136
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

EDGARDO REYES-AYALA M.D.

Geriatric Medicine

6,063

$389K

306
270 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $56

RAFAEL BARRIAL MD

Geriatric Medicine

5,078

$321K

279
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

R BONILLA M.D.

Geriatric Medicine

1,812

$141K

130
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $56

SYEDA RIZVI MD

Geriatric Medicine

7,691

$335K

700
515 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

ANDREA SCHEIN M.D.

Geriatric Medicine

1,693

$79.8K

93
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $56

ALAN GOLDBLATT M.D.

Geriatric Medicine

4,036

$245K

237
227 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $56

DEBORAH FRIEDLANDER M.D.

Geriatric Medicine

6,910

$436K

508
456 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $56

VASYL KASIYAN M.D.

Geriatric Medicine

5,517

$244K

229
209 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $56

HAZEM EL-AROUSY M.D

Geriatric Medicine

2,513

$54.7K

1311
1191 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

4%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 25%

$22
Average prescription price

Avg: $56

HANIMI CHALLA M.D.

Geriatric Medicine

23,194

$1.08M

1539
1414 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $56

JANE KIENLE MD

Geriatric Medicine

3,115

$249K

202
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $56

RENUKA TUNUGUNTLA M.D.

Geriatric Medicine

3,281

$147K

134
129 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

MIGUEL GONZALEZ MD

Geriatric Medicine

16,771

$752K

670
584 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $56

DIANE CLARKE M.D

Geriatric Medicine

3,834

$120K

354
320 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

5%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$31
Average prescription price

Avg: $56

PAL DURAI MD

Geriatric Medicine

11,135

$405K

492
436 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$36
Average prescription price

Avg: $56

RAFAEL COTT M.D.

Geriatric Medicine

7,126

$460K

370
358 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $56

RICHARD WILLIAMS M.D.

Geriatric Medicine

1,034

$42.1K

173
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank